Paper reports overview: Mortality and morbidity prediction and reduction in the high risk patient by Venn, Richard & Philips, Barbara
30
Paper reports
19 November 1999 – 13 January 2000
http://ccforum.com/4/1/030
Mortality and morbidity prediction and reduction in the high risk
patient
Richard Venn and Barbara Philips
Department of Intensive Care, St George’s Hospital, London, UK
The high-risk patient is a much talked about entity in inten-
sive care circles, but identification of these patients still
consumes an abundance of research material. The search
continues for that elusive symptom, sign or investigation
which has a high sensitivity and specificity. Several of the
paper reports over the last couple of months have focused
on ways to predict mortality in those patients considered to
be high risk. Cole et al looked at heart rate recovery follow-
ing maximum treadmill stress testing in patients referred for
this investigation and therefore presumably presenting with
cardiac symptoms and signs. They found that this relatively
simple and non-invasive investigation predicted a worse
outcome if the heart rate failed to decline rapidly after exer-
cise. Mortality at 6 years was 19% compared to 5% in
those patients with a normal heart rate recovery. Perhaps
this investigation may help us perioperatively identify those
at high risk of cardiac events.
Smith  et al looked at Therapeutic Intervention Scoring
System (TISS) scores to see whether they could help in
the decision process regarding discharge from the inten-
sive care unit (ICU) and in particular highlight those dis-
charges with a poor outcome after leaving the ICU. They
concluded that patients with a TISS score between 10
and 19 should not be discharged to the ward but receive
some intermediate care facility. Only when the TISS score
was below 10 was ward care appropriate. In the cardiac
ICU, Wong et al used multiple logistic regression models
for identifying independent risk factors for delayed extuba-
tion, prolonged ICU length of stay and mortality following
coronary artery bypass graft (CABG) surgery. Periopera-
tive rather than preoperative variables were important in
predicting delayed extubation with the risk factors for mor-
tality being female sex, emergency surgery and poor left
ventricular function, which are already used in other
scoring systems.
Two very important papers have appeared in the New
England Journal of Medicine over the last two months.
The Heart Outcomes Prevention Evaluation Study Investi-
gators have highlighted the reduction in mortality in
patients treated with the angiotensin converting enzyme
(ACE) inhibitor, ramipril. The significance of this paper was
that these patients were not known to have heart failure or
a low ejection fraction and so it broadens the use of ACE
inhibitors to many more patients who have risk factors for
cardiovascular disease. The Dutch Echocardiographic
Cardiac Risk Evaluation Applying Stress Echocardiogra-
phy Study Group has published extremely important
results for the high-risk surgical patient. They have shown
a dramatic reduction in cardiac events with the use of the
cardioselective beta-blocker bisoprolol in the perioperative
period, in high-risk patients undergoing major vascular
surgery (34% in the control group compared to 3.4%).
This study will presumably change clinical practice but
leaves many questions unanswered, such as the timing of
introduction of beta-blockade preoperatively, the use of
alternative beta-blockers and the treatment of those
patients without a positive result during dobutamine
echocardiography. Perhaps this latter group will benefit
from optimisation with beta-agonists — a diametrically
opposite pharmacological approach, which has also
shown encouraging results.
Robertson  et al investigated whether they could affect
outcome following head injury by targeting cerebral blood
flow via increases in mean arterial pressure. Unfortunately,
although they concluded that secondary ischaemic insults
caused by systemic factors could be prevented with a tar-
geted management protocol, this was offset by an unex-
plained fivefold increase in the frequency of adult
respiratory distress syndrome (ARDS), and there was no
difference in neurological outcome.
Two further papers report on the benefits of hyperthermia
on the immune system on the one hand and those of
hypothermia in acute liver failure on the other. In a rat
model of peritonitis, Ozveri et al showed that hyperthermic
preconditioning improves immune system function, and
there was a trend towards improved 7-day survival in the
hyperthermic preconditioned rats, although this did not
reach statistical significance. Moderate hypothermia inhttp://ccforum.com/4/1/030
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patients with acute liver failure resulted in a significant drop
in intra-cranial pressure (ICP) in patients with uncontrolled
intracranial hypertension which is frequently the cause of
death in these patients (Jalan et al). Anything that length-
ens survival for the patient awaiting liver transplantation is a
bonus. However, little benefit has previously been shown in
neurological centres using hypothermia and so a random-
ized controlled trial is needed for this therapy. This high-
lights the problems we have with diametrically opposed
therapies showing benefits to one organ system but which
may be detrimental to another.
Finally, well worth a read is the hypothesis proposed by
Laffey and Kavanagh that hypercapnia is good for you. Cer-
tainly they give an interesting and very plausible perspective
on ‘permissive hypercapnia’, arguing that it is the carbon
dioxide that offers you the survival advantage rather than the
reduced mechanical stresses inflicted on the lungs. This
highlights another feature of paper reporting where we
hope to provide brief comments and hyperlinks to important
journal reviews on topics of interest in intensive care.
Authors’ affiliation: Department of Intensive Care, St George’s
Hospital, Blackshaw Road, London SW17 0QT, UK